Cassava Sciences
SAVA
#8806
Rank
NZ$0.27 B
Marketcap
NZ$5.60
Share price
1.25%
Change (1 day)
11.30%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.25 Billion a decrease over its 2023 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion-21.95%
2024 -NZ$0.25 Billion34.28%
2023 -NZ$0.19 Billion32.41%
2022 -NZ$0.14 Billion143.46%
2021 -NZ$56.86 Million383.92%
2020 -NZ$11.75 Million36.96%
2019 -NZ$8.58 Million-25.56%
2018 -NZ$11.53 Million-44.25%
2017 -NZ$20.67 Million-20.11%
2016 -NZ$25.88 Million5.32%
2015 -NZ$24.57 Million14.23%
2014 -NZ$21.51 Million-139.64%
2013 NZ$54.25 M
2010 -NZ$23.71 Million102.87%
2009 -NZ$11.69 Million-177.52%
2008 NZ$15.07 M-14.32%
2007 NZ$17.58 M-1942.21%
2006 -NZ$0.96 Million
2004 -NZ$67.4 Million75.1%
2003 -NZ$38.49 Million
2001 -NZ$29.95 Million20.49%
2000 -NZ$24.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA